Work

Subcutaneous Epcoritamab in Combination with R-CHOP in Patients with Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma: Preliminary Results from a Phase 1/2 Trial

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-146569

Authors: David Belada, Jacob Haaber Christensen, Kristina Drott, Sylvia Snauwaert, Joshua Brody, Mayur Narkhede, Fritz Offner, Brian Elliot, Tracy Liu, Mariana Cota Stirner, Aqeel Abbas, Lorenzo Falchi, Michael Roost Clausen

Institutions: University Hospital Hradec Králové, Odense University Hospital, Skåne University Hospital, AZ Sint-Jan, Icahn School of Medicine at Mount Sinai, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Ghent University Hospital, Genmab (United States), AbbVie (United States), Memorial Sloan Kettering Cancer Center, Vejle Sygehus

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3214504952

Cites:

Cited by: 9

Related to: 10